This NDC is on FDA's drug shortage list (posted Jul 26, 2023)

Reported reason: Other

Product Information

METHYLPHENIDATE ER 27 MG TAB is a generic product labeled by Lannett Company Inc., priced at $0.7200 per EA under NDC 62175031137. Its NADAC has been published 674 times since Nov 28, 2013.

FDA first approved this application on Jul 9, 2013. Its Orange Book therapeutic-equivalence code is BX.

METHYLPHENIDATE ER 27 MG TAB

Methylphenidate Hydrochloride
$0.7200per EA
DEA Schedule CII

Strength

27 mg/1

NDC

62175031137

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA091695

FDA Approved

7/9/2013

TE Code

BX

On Market Since

7/10/2013

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for METHYLPHENIDATE ER 27 MG TAB has been published 674 times since Nov 28, 2013, and over the history we have for it it has declined 84.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7200 per EA
All-time high$7.6422 (Mar 14, 2018)
All-time low$0.5744 (Jul 20, 2022)
52-week high$0.7200
52-week low$0.6242
Median price$2.3817
Average price$2.9575
Largest weekly change+134.6% (Sep 20, 2017)
Weeks tracked674
Tracking sinceNov 28, 2013

Price History

1W

+0.2%

1M

+6.4%

3M

+11.7%

6M

+13.2%

1Y

+8.3%

3Y

+2.4%

5Y

+2.3%

All

-84.8%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METHYLPHENIDATE ER 27 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER 27 MG TAB, manufactured by Lannett Company Inc., is $0.7200 per EA (NDC 62175031137), effective Nov 18, 2026.

How has the price of METHYLPHENIDATE ER 27 MG TAB changed over time?

Over the history we have for it, the NADAC for METHYLPHENIDATE ER 27 MG TAB has declined 84.8%. It has been tracked across 674 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER 27 MG TAB?

Since Nov 28, 2013, the NADAC for METHYLPHENIDATE ER 27 MG TAB has ranged from a low of $0.5744 (Jul 20, 2022) to a high of $7.6422 (Mar 14, 2018), with a median of $2.3817 per EA.

Are there cheaper alternatives to METHYLPHENIDATE ER 27 MG TAB?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE ER 27 MG TAB, is $0.6446 per EA — about 10% below METHYLPHENIDATE ER 27 MG TAB.

Who manufactures METHYLPHENIDATE ER 27 MG TAB?

METHYLPHENIDATE ER 27 MG TAB (NDC 62175031137) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.

Is METHYLPHENIDATE ER 27 MG TAB in shortage?

Yes — NDC 62175031137 is currently listed in FDA's drug shortage database (posted Jul 26, 2023). Reported reason: Other.